BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16288217)

  • 1. Smad4 haploinsufficiency in mouse models for intestinal cancer.
    Alberici P; Jagmohan-Changur S; De Pater E; Van Der Valk M; Smits R; Hohenstein P; Fodde R
    Oncogene; 2006 Mar; 25(13):1841-51. PubMed ID: 16288217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serrated adenomas and mixed polyposis caused by a splice acceptor deletion in the mouse Smad4 gene.
    Hohenstein P; Molenaar L; Elsinga J; Morreau H; van der Klift H; Struijk A; Jagmohan-Changur S; Smits R; van Kranen H; van Ommen GJ; Cornelisse C; Devilee P; Fodde R
    Genes Chromosomes Cancer; 2003 Mar; 36(3):273-82. PubMed ID: 12557227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No effects of Smad2 (madh2) null mutation on malignant progression of intestinal polyps in Apc(delta716) knockout mice.
    Takaku K; Wrana JL; Robertson EJ; Taketo MM
    Cancer Res; 2002 Aug; 62(16):4558-61. PubMed ID: 12183405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression.
    Janssen KP; Alberici P; Fsihi H; Gaspar C; Breukel C; Franken P; Rosty C; Abal M; El Marjou F; Smits R; Louvard D; Fodde R; Robine S
    Gastroenterology; 2006 Oct; 131(4):1096-109. PubMed ID: 17030180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haploid loss of the tumor suppressor Smad4/Dpc4 initiates gastric polyposis and cancer in mice.
    Xu X; Brodie SG; Yang X; Im YH; Parks WT; Chen L; Zhou YX; Weinstein M; Kim SJ; Deng CX
    Oncogene; 2000 Apr; 19(15):1868-74. PubMed ID: 10773876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation.
    Muñoz NM; Upton M; Rojas A; Washington MK; Lin L; Chytil A; Sozmen EG; Madison BB; Pozzi A; Moon RT; Moses HL; Grady WM
    Cancer Res; 2006 Oct; 66(20):9837-44. PubMed ID: 17047044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compound disruption of smad2 accelerates malignant progression of intestinal tumors in apc knockout mice.
    Hamamoto T; Beppu H; Okada H; Kawabata M; Kitamura T; Miyazono K; Kato M
    Cancer Res; 2002 Oct; 62(20):5955-61. PubMed ID: 12384562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myh deficiency enhances intestinal tumorigenesis in multiple intestinal neoplasia (ApcMin/+) mice.
    Sieber OM; Howarth KM; Thirlwell C; Rowan A; Mandir N; Goodlad RA; Gilkar A; Spencer-Dene B; Stamp G; Johnson V; Silver A; Yang H; Miller JH; Ilyas M; Tomlinson IP
    Cancer Res; 2004 Dec; 64(24):8876-81. PubMed ID: 15604247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric and duodenal polyps in Smad4 (Dpc4) knockout mice.
    Takaku K; Miyoshi H; Matsunaga A; Oshima M; Sasaki N; Taketo MM
    Cancer Res; 1999 Dec; 59(24):6113-7. PubMed ID: 10626800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Robertsonian translocation suppresses a somatic recombination pathway to loss of heterozygosity.
    Haigis KM; Dove WF
    Nat Genet; 2003 Jan; 33(1):33-9. PubMed ID: 12447373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced tumor formation in mice heterozygous for Blm mutation.
    Goss KH; Risinger MA; Kordich JJ; Sanz MM; Straughen JE; Slovek LE; Capobianco AJ; German J; Boivin GP; Groden J
    Science; 2002 Sep; 297(5589):2051-3. PubMed ID: 12242442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells.
    Deckers M; van Dinther M; Buijs J; Que I; Löwik C; van der Pluijm G; ten Dijke P
    Cancer Res; 2006 Feb; 66(4):2202-9. PubMed ID: 16489022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of SMAD4 tumor suppressor gene during gastric carcinoma progression.
    Wang LH; Kim SH; Lee JH; Choi YL; Kim YC; Park TS; Hong YC; Wu CF; Shin YK
    Clin Cancer Res; 2007 Jan; 13(1):102-10. PubMed ID: 17200344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity in spontaneous and X-ray-induced intestinal tumors arising in F1 hybrid min mice: evidence for sequential loss of APC(+) and Dpc4 in tumor development.
    Haines J; Dunford R; Moody J; Ellender M; Cox R; Silver A
    Genes Chromosomes Cancer; 2000 Aug; 28(4):387-94. PubMed ID: 10862047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E-cadherin and adenomatous polyposis coli mutations are synergistic in intestinal tumor initiation in mice.
    Smits R; Ruiz P; Diaz-Cano S; Luz A; Jagmohan-Changur S; Breukel C; Birchmeier C; Birchmeier W; Fodde R
    Gastroenterology; 2000 Oct; 119(4):1045-53. PubMed ID: 11040191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia.
    Kojima K; Vickers SM; Adsay NV; Jhala NC; Kim HG; Schoeb TR; Grizzle WE; Klug CA
    Cancer Res; 2007 Sep; 67(17):8121-30. PubMed ID: 17804724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas.
    Izeradjene K; Combs C; Best M; Gopinathan A; Wagner A; Grady WM; Deng CX; Hruban RH; Adsay NV; Tuveson DA; Hingorani SR
    Cancer Cell; 2007 Mar; 11(3):229-43. PubMed ID: 17349581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/+) mice attenuates intestinal tumorigenesis.
    Zeilstra J; Joosten SP; Dokter M; Verwiel E; Spaargaren M; Pals ST
    Cancer Res; 2008 May; 68(10):3655-61. PubMed ID: 18483247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated Dnmt3a activity promotes polyposis in Apc(Min) mice by relaxing extracellular restraints on Wnt signaling.
    Samuel MS; Suzuki H; Buchert M; Putoczki TL; Tebbutt NC; Lundgren-May T; Christou A; Inglese M; Toyota M; Heath JK; Ward RL; Waring PM; Ernst M
    Gastroenterology; 2009 Sep; 137(3):902-13, 913.e1-11. PubMed ID: 19454286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smad4 signalling in T cells is required for suppression of gastrointestinal cancer.
    Kim BG; Li C; Qiao W; Mamura M; Kasprzak B; Anver M; Wolfraim L; Hong S; Mushinski E; Potter M; Kim SJ; Fu XY; Deng C; Letterio JJ
    Nature; 2006 Jun; 441(7096):1015-9. PubMed ID: 16791201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.